Steven Maestrello, MD
Rheumatology · Richmond, VANPI 1154328938
Payments from drug & device makers
Across 475 payments — averaging $18.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- AbbVie$1K
- Pfizer$734
- Novartis$609
- Johnson & Johnson$607
- Lilly USA, LLC$595
- plus $3K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 82 | $1,460 |
| AbbVie | 86 | $1,079 |
| Pfizer | 55 | $734 |
| Novartis | 26 | $609 |
| Johnson & Johnson | 48 | $607 |
| Lilly USA, LLC | 24 | $595 |
| UCB, Inc. | 16 | $382 |
| E.r. Squibb & Sons, L.L.C. | 15 | $299 |
| Genentech USA, Inc. | 12 | $296 |
| Mallinckrodt Hospital Products Inc. | 10 | $296 |
| AstraZeneca | 13 | $292 |
| GSK | 14 | $250 |
| Radius Health, Inc. | 8 | $230 |
| ANI Pharmaceuticals, Inc. | 7 | $171 |
| Boehringer Ingelheim | 5 | $140 |
| Aurinia Pharma U.S., Inc. | 7 | $136 |
| Sandoz | 6 | $135 |
| Fresenius Kabi USA, LLC | 6 | $108 |
| Sanofi | 4 | $100 |
| Organon | 8 | $95 |
| Fidia Pharma USA Inc. | 3 | $66 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $65 |
| Tersera Therapeutics LLC | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Boston Scientific | 1 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Sobi, Inc | 1 | $28 |
| Mylan Institutional Inc. | 1 | $25 |
| Tonix Medicines, Inc. | 1 | $25 |
| Celltrion USA Inc. | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| Bristol Myers Squibb | 1 | $17 |
| Bioventus LLC | 1 | $14 |
How this compares
$8,548 in reported general payments places this provider in the 65th percentile of 159 rheumatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Richmond
- Michael StrachanRichmond$158K
- Karim MasriRichmond$147K
- Tammy SpringRichmond$17K
- Mihail MoroianuRichmond$13K
- Bhakti JoshiRichmond$12K
- Peter CoutlakisRichmond$12K
- Avnit AhujaRichmond$12K
- Nehal ShahRichmond$8K
- Peter LipskyCharlottesville$1.6M
- Sharukh ShroffDanville$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.